Concepedia

J. Seroogy

JS

5

Publications

179

Citations

5

H-Index

2001

Active since

Affiliations

Rapt Therapeutics (United States)(Current)

Millennium Engineering and Integration (United States)

J. Seroogy is an author at Rapt Therapeutics (United States) specializing in drug development, pharmacotherapy, and drug discovery.

Top concepts

Publications per year

2001–2004

5

Publications

5

Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family

Anjali Pandey, Deborah L. Volkots, J. Seroogy et al. · Journal of Medicinal Chemistry · 2002 · 114 citations · Full text

Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes

Mukund M. Mehrotra, Julie A. Heath, Jack W. Rose et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 17 citations · Full text

, , +8

Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 1: design of potent and specific 3,9-diazaspiro[5.5]undecanes

Mark S. Smyth, Jack W. Rose, Mukund M. Mehrotra et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 17 citations · Full text

, , +11

Discovery of Novel 2,8-Diazaspiro[4.5]decanes as Orally Active Glycoprotein IIb-IIIa Antagonists

Mukund M. Mehrotra, Julie A. Heath, Mark S. Smyth et al. · Journal of Medicinal Chemistry · 2004 · 17 citations · Full text

, , +14

Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 2: design of potent antagonists containing the 3-azaspiro[5.5]undec-9-yl template

Anjali Pandey, J. Seroogy, Deborah L. Volkots et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 14 citations · Full text

, , +8

Rows per page

1–5 of 5